医学全在线
医学全在线首页-医师-药师-护士-卫生资格-高级职称-考试题库-网校-考研-图谱-下载-招聘  
分类
国家级省级浙江省各省杂志
科技核心北大核心CSCDCSCD扩展
工具
期刊知识写作指导 论文投稿推荐期刊
期刊验证论文检测 录用通知往期目录
SCI
SCI指导影响因子
期刊点评基金动态
其它
经济教育计算机
建筑体育农业
北京|天津|河北|山西|湖北|江苏|安徽|山东|上海|浙江|江西|福建|湖南|宁夏|内蒙古|河南
四川|重庆|贵州|云南|辽宁|吉林|广东|广西|海南|陕西|甘肃|新疆|青海|卫生部直属|黑龙江|兵团
您现在的位置: 医学全在线 > 医学论文 > 论文投稿 > 正文:医学免费论文:TACE、PEI双介入间隔疗法治疗晚期原发性肝细胞癌临床观察
    

医学免费论文:TACE、PEI双介入间隔疗法治疗晚期原发性肝细胞癌临床观察

来源:本站原创 更新:2013-10-9 论文投稿平台

医学免费论文:TACE、PEI双介入间隔疗法治疗晚期原发性肝细胞癌临床观察

【摘要】  目的 对照观察肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)和经皮肝穿刺无水乙醇注射(percutaneous ethanol injection,PEI)双介入间隔疗法治疗晚期原发性肝细胞癌(hepatocellular carcinoma,HCC)临床效果。方法 观察组25例采用间隔2周进行TACE、PEI分别配合治疗,每疗程TACE 2~3次、PEI 2~4次。对照组29例单纯进行TACE治疗。两组观察期3年。结果 观察组1年内生存率与对照组相比无明显差异,2年、3年内生存率高于对照组(P<0.05);观察组肿瘤缩小总有效率高于对照组(P<0.05)。结论 TACE、PEI间隔双介入疗法较单纯TACE治疗晚期原发性肝细胞癌能够提高治疗效果,延长患者存活时间,改善生存质量。

【关键词】  原发性肝细胞癌; 肝动脉化疗栓塞术; 经皮肝穿刺无水乙醇注射

Clinical observation of treating the primary hepatocellular carcinoma in the advanced stage by using TACE and PEI  ZHONG Liqing,XU yincong,LU longhui,et al.Department of Xray,the 123rd Hospital of PLA,Bengbu  233015,China医.学.全.在.线www.med126.com

【Abstract】  Objective  To comparatively observe the clinical efficacy of transcatheter arterial chemoembolization(TACE) combined with percutaneous ethanol injection (PEI)in the treatment of primary hepatocellular carcinoma (HCC) in the advanced stage. Methods  The observation group (25 cases) were treated with TACE and PEI with intervals about two weeks. Each course of treatment included 2 to 3 times of TACE and 2 to 4 times of PEI.The control group (29 cases) were treated only with TACE. All the two groups were observed for 3 years. Results  The survival rate of the two groups had no remarkable difference in one year, but the survival rate of observation group was higher than that of the control group in two or three years(P<0.05).The total effective rate of tumor reduction in the observation group was higher than that of the control group(P<0.05). Conclusion  Compared with the single TACE treatment, TACE combined with PEI treatment for the advanced primary HCC can improve the therapeutic efficacy and extend the survival time and improve the quality of life of patients.

【Key words】  Primary hepatocellular carcinoma;Transcatheter arterial chemoembolization;Percutaneous ethanol injection

对于不能手术切除的晚期原发性肝细胞癌(hepatocellular carcinoma ,HCC),目前采用的姑息疗法是肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)和经皮肝穿刺无水乙醇注射(percutaneous ethanol injection,PEI)。我院采用TACE、PEI间隔疗法治疗HCC患者25例,取得较好疗效。


[1] [2] [3] [4] 下一页

...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP备12017320号
百度大联盟认证绿色会员实名网站 360认证可信网站 中网验证